Updated Jul 16, 2026
Redfield Robert has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Robert Redfield is the Chief Medical Officer at Traws Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing antiviral therapies for respiratory viral diseases. He has been involved in the company's efforts to advance investigational antiviral agents.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-16 | TRAW | Traws Pharma, Inc. | A — Grant or award | 16.4K | $0.00 |
Robert Redfield is the Chief Medical Officer at Traws Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing antiviral therapies for respiratory viral diseases. He has been involved in the company's efforts to advance investigational antiviral agents.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Redfield Robert profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.